Browsing by Author "Besiroglu, Mehmet"
Now showing items 1-3 of 3
-
Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer
Topcu, Atakan; Atci, Muhammed Mustafa; Secmeler, Saban; Besiroglu, Mehmet; Ayhan, Murat; Ozkan, Metin; Bozkurt, Oktay (Future Medicine Ltd, 2021)Gastric cancer has a poor prognosis despite available treatments. Inclusive studies are still needed with real-life data. Our research retrospectively evaluated the efficacy of trastuzumab and potential risk factors on ... -
Multicenter Epidemiologic Study on Hepatocellular Carcinoma in Turkey
Can, Alper; Dogan, Erkan; Bayoglu, Ibrahim Vedat; Tatli, Ali Murat; Besiroglu, Mehmet; Kocer, Murat; Dulger, Ahmet Cumhur (Asian Pacific Organization Cancer Prevention, 2014)Background: Hepatocellular cancer (HCC) is one of the important health problems in Turkey, being very common and highly lethal. The aim of this study was to determine clinical, demographic features and risk factors. Materials ... -
Pazopanib for metastatic soft-tissue sarcoma: A multicenter retrospective study
Koca, Sinan; Besiroglu, Mehmet; Ozcelik, Melike; Karaca, Mustafa; Bilici, Mehmet; Hacioglu, Bekir; Dogu, Gamze G. (Sage Publications Ltd, 2021)Purpose Soft tissue sarcomas are associated with a poor prognosis and low chemotherapeutic efficiency. Pazopanib is an orally available multi-tyrosine kinase inhibitor that was explored in patients with non-adipocytic ...